Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Cancer Biology
  • View item
  • Home
  • ICR Divisions
  • Cancer Biology
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Adenoviral strategies for the gene therapy of cancer.

Thumbnail
Date
2005-12
ICR Author
Harrington, Kevin
Author
Relph, KL
Harrington, KJ
Pandha, H
Type
Other
Metadata
Show full item record
Abstract
Despite slow clinical progress, efforts to develop specific nontoxic cancer gene therapies are increasing exponentially. Adenoviral vectors are one of the most popular vehicles for gene transfer currently being used in worldwide clinical trials for cancer. Over the past decade our knowledge of the adenoviral life cycle together with the discovery of novel tumor antigens has permitted the targeting of adenoviral vectors to specific tumors. Targeting adenoviral vectors to tumors is crucial for their use in clinical applications in order to allow for systemic administration and the use of reduced vector doses. In addition, novel approaches to tumor killing have also been explored, which will have greater potency and selectivity than currently available treatments such as chemotherapy or radiation. This review discusses the basic concepts behind the use of adenoviral vectors for cancer gene therapy and their potential for clinical application, as well as ongoing and completed clinical trials.
URI
https://repository.icr.ac.uk/handle/internal/1725
DOI
https://doi.org/10.1053/j.seminoncol.2005.09.001
Collections
  • Cancer Biology
  • Radiotherapy and Imaging
Subject
Humans
Adenoviridae
Neoplasms
Antigens, Neoplasm
Immunotherapy
Gene Transfer Techniques
Genes, Transgenic, Suicide
Genetic Vectors
Oncolytic Virotherapy
Clinical Trials as Topic
Genetic Therapy
Research team
Targeted Therapy
Language
eng
License start date
2005-12
Citation
Seminars in oncology, 2005, 32 (6), pp. 573 - 582

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.